• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 MRI/RNA-Seq 的放射基因组学和人工智能在肌肉浸润性膀胱癌更准确分期中的应用。

MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder Cancer.

机构信息

Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Department of Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

出版信息

Int J Mol Sci. 2023 Dec 20;25(1):88. doi: 10.3390/ijms25010088.

DOI:10.3390/ijms25010088
PMID:38203254
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10778815/
Abstract

Accurate staging of bladder cancer assists in identifying optimal treatment (e.g., transurethral resection vs. radical cystectomy vs. bladder preservation). However, currently, about one-third of patients are over-staged and one-third are under-staged. There is a pressing need for a more accurate staging modality to evaluate patients with bladder cancer to assist clinical decision-making. We hypothesize that MRI/RNA-seq-based radiogenomics and artificial intelligence can more accurately stage bladder cancer. A total of 40 magnetic resonance imaging (MRI) and matched formalin-fixed paraffin-embedded (FFPE) tissues were available for analysis. Twenty-eight (28) MRI and their matched FFPE tissues were available for training analysis, and 12 matched MRI and FFPE tissues were used for validation. FFPE samples were subjected to bulk RNA-seq, followed by bioinformatics analysis. In the radiomics, several hundred image-based features from bladder tumors in MRI were extracted and analyzed. Overall, the model obtained mean sensitivity, specificity, and accuracy of 94%, 88%, and 92%, respectively, in differentiating intra- vs. extra-bladder cancer. The proposed model demonstrated improvement in the three matrices by 17%, 33%, and 25% and 17%, 16%, and 17% as compared to the genetic- and radiomic-based models alone, respectively. The radiogenomics of bladder cancer provides insight into discriminative features capable of more accurately staging bladder cancer. Additional studies are underway.

摘要

膀胱癌的准确分期有助于确定最佳治疗方法(例如,经尿道膀胱肿瘤切除术与根治性膀胱切除术与膀胱保留)。然而,目前约有三分之一的患者分期过高,三分之一的患者分期过低。迫切需要一种更准确的分期方式来评估膀胱癌患者,以协助临床决策。我们假设 MRI/RNA-seq 为基础的放射组学和人工智能可以更准确地分期膀胱癌。共获得 40 份磁共振成像(MRI)和匹配的福尔马林固定石蜡包埋(FFPE)组织进行分析。28 份 MRI 及其匹配的 FFPE 组织用于训练分析,12 份匹配的 MRI 和 FFPE 组织用于验证。FFPE 样本进行了批量 RNA-seq 分析,然后进行了生物信息学分析。在放射组学中,从 MRI 中的膀胱癌中提取并分析了数百个基于图像的特征。总的来说,该模型在区分膀胱内与膀胱外癌症方面,分别获得了 94%、88%和 92%的平均敏感性、特异性和准确性。与单独基于遗传和放射组学的模型相比,该模型在三个矩阵中分别提高了 17%、33%和 25%,以及 17%、16%和 17%。膀胱癌的放射组学提供了有鉴别能力的特征,可以更准确地分期膀胱癌。正在进行更多的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572e/10778815/63c4b9c80558/ijms-25-00088-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572e/10778815/777445297b68/ijms-25-00088-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572e/10778815/6a05cf9c4fdb/ijms-25-00088-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572e/10778815/63c4b9c80558/ijms-25-00088-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572e/10778815/777445297b68/ijms-25-00088-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572e/10778815/6a05cf9c4fdb/ijms-25-00088-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572e/10778815/63c4b9c80558/ijms-25-00088-g003.jpg

相似文献

1
MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder Cancer.基于 MRI/RNA-Seq 的放射基因组学和人工智能在肌肉浸润性膀胱癌更准确分期中的应用。
Int J Mol Sci. 2023 Dec 20;25(1):88. doi: 10.3390/ijms25010088.
2
[Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection].[膀胱癌肌层浸润的局部分期:经尿道切除术后3.0T MRI的表现]
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Aug 18;52(4):701-704. doi: 10.19723/j.issn.1671-167X.2020.04.020.
3
Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer.将 DWI 放射组学特征与经尿道切除术相结合,可促进肌层浸润性膀胱癌和非肌层浸润性膀胱癌的鉴别。
Eur Radiol. 2020 Mar;30(3):1804-1812. doi: 10.1007/s00330-019-06484-2. Epub 2019 Nov 26.
4
Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations.当代肌层浸润性膀胱癌分期:准确性和局限性。
Eur Urol Oncol. 2022 Aug;5(4):403-411. doi: 10.1016/j.euo.2022.04.008. Epub 2022 May 14.
5
Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.膀胱多参数 MRI:在单一参考中心使用 Vesical Imaging-Reporting and Data System(VI-RADS)的观察者间一致性和准确性。
Eur Radiol. 2019 Oct;29(10):5498-5506. doi: 10.1007/s00330-019-06117-8. Epub 2019 Mar 18.
6
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.前瞻性评估膀胱影像报告和数据系统(VI-RADS)及其对高危非肌肉浸润性膀胱癌患者重复经尿道切除术候选者管理的临床影响。
Eur Urol. 2020 Jan;77(1):101-109. doi: 10.1016/j.eururo.2019.09.029. Epub 2019 Nov 5.
7
Role of Radiomics in the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.基于放射组学的膀胱癌肌层浸润预测:系统综述与 Meta 分析。
Eur Urol Focus. 2022 May;8(3):728-738. doi: 10.1016/j.euf.2021.05.005. Epub 2021 Jun 5.
8
Bladder cancer local staging: multiparametric MRI performance following transurethral resection.膀胱癌局部分期:经尿道切除术后多参数 MRI 的性能。
Abdom Radiol (NY). 2018 Sep;43(9):2412-2423. doi: 10.1007/s00261-017-1449-0.
9
Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?术前膀胱成像报告和数据系统(VI-RADS)评分 5 可可靠识别膀胱癌的膀胱外延伸,并预测显著的膀胱切除术延迟时间:是否需要重新考虑局部进展性疾病患者行原发性经尿道膀胱肿瘤深度切除术?
BJU Int. 2020 Nov;126(5):610-619. doi: 10.1111/bju.15188. Epub 2020 Aug 17.
10
Quantitative Identification of Nonmuscle-Invasive and Muscle-Invasive Bladder Carcinomas: A Multiparametric MRI Radiomics Analysis.定量识别非肌层浸润性和肌层浸润性膀胱癌:多参数 MRI 放射组学分析。
J Magn Reson Imaging. 2019 May;49(5):1489-1498. doi: 10.1002/jmri.26327. Epub 2018 Sep 25.

引用本文的文献

1
Enhancing the breeding gene pool of wheat using accessions in gene banks as demonstrated by the Watkins collection.如沃特金斯种质库所示,利用基因库中的种质资源提升小麦育种基因库。
Theor Appl Genet. 2025 May 5;138(6):109. doi: 10.1007/s00122-025-04898-9.
2
Recent Advances and Emerging Innovations in Transurethral Resection of Bladder Tumor (TURBT) for Non-Muscle Invasive Bladder Cancer: A Comprehensive Review of Current Literature.非肌层浸润性膀胱癌经尿道膀胱肿瘤切除术(TURBT)的最新进展与新兴创新:当前文献综述
Res Rep Urol. 2025 Mar 14;17:69-85. doi: 10.2147/RRU.S386026. eCollection 2025.
3
Association of radiomic features with genomic signatures in thyroid cancer: a systematic review.

本文引用的文献

1
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
2
Radiogenomics, Breast Cancer Diagnosis and Characterization: Current Status and Future Directions.放射基因组学、乳腺癌诊断与特征分析:现状与未来方向
Methods Protoc. 2022 Oct 3;5(5):78. doi: 10.3390/mps5050078.
3
Glioma radiogenomics and artificial intelligence: road to precision cancer medicine.神经胶质瘤放射基因组学与人工智能:通往精准癌症医学之路
基于影像组学特征与甲状腺癌基因组特征的相关性:一项系统综述。
J Transl Med. 2024 Nov 30;22(1):1088. doi: 10.1186/s12967-024-05896-z.
4
Artificial intelligence application in the diagnosis and treatment of bladder cancer: advance, challenges, and opportunities.人工智能在膀胱癌诊断与治疗中的应用:进展、挑战与机遇。
Front Oncol. 2024 Nov 7;14:1487676. doi: 10.3389/fonc.2024.1487676. eCollection 2024.
5
From Images to Genes: Radiogenomics Based on Artificial Intelligence to Achieve Non-Invasive Precision Medicine in Cancer Patients.从图像到基因:基于人工智能的放射基因组学助力癌症患者实现无创精准医疗
Adv Sci (Weinh). 2025 Jan;12(2):e2408069. doi: 10.1002/advs.202408069. Epub 2024 Nov 13.
Clin Radiol. 2023 Feb;78(2):137-149. doi: 10.1016/j.crad.2022.08.138. Epub 2022 Oct 11.
4
The origin of bladder cancer from mucosal field effects.膀胱癌源于黏膜场效应。
iScience. 2022 Jun 7;25(7):104551. doi: 10.1016/j.isci.2022.104551. eCollection 2022 Jul 15.
5
Role of Artificial Intelligence in Radiogenomics for Cancers in the Era of Precision Medicine.精准医学时代人工智能在癌症放射基因组学中的作用
Cancers (Basel). 2022 Jun 9;14(12):2860. doi: 10.3390/cancers14122860.
6
CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic Outcomes.基于 CT 的临床Ⅰ期肺腺癌影像学基因组分析:与组织病理学特征和肿瘤学结局的关系。
Radiology. 2022 Jun;303(3):664-672. doi: 10.1148/radiol.211582. Epub 2022 Mar 1.
7
Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images.利用人工智能分析术前 CT 图像预测胰腺导管腺癌。
Cancer Biomark. 2022;33(2):211-217. doi: 10.3233/CBM-210273.
8
F-FDG PET/CT Radiomics for Preoperative Prediction of Lymph Node Metastases and Nodal Staging in Gastric Cancer.用于术前预测胃癌淋巴结转移及淋巴结分期的F-FDG PET/CT影像组学
Front Oncol. 2021 Sep 13;11:723345. doi: 10.3389/fonc.2021.723345. eCollection 2021.
9
An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer.表达N-钙黏蛋白2的上皮细胞亚群可预测膀胱癌对手术、化疗和免疫治疗的反应。
Nat Commun. 2021 Aug 12;12(1):4906. doi: 10.1038/s41467-021-25103-7.
10
A radiomics-based nomogram for preoperative T staging prediction of rectal cancer.基于放射组学的直肠癌术前 T 分期预测列线图。
Abdom Radiol (NY). 2021 Oct;46(10):4525-4535. doi: 10.1007/s00261-021-03137-1. Epub 2021 Jun 3.